Financhill
Back

Sutro Biopharma, Inc. 10K Form

Sell
37

STRO
Sutro Biopharma, Inc.

Last Price:
$23.63
Seasonality Move:
-7.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive STRO News And Ratings

See the #1 stock for the next 7 days that we like better than STRO

STRO Financial Statistics

Sales & Book Value

Annual Sales: $102.5M
Cash Flow: $-26.6M
Price / Cash Flow: 0
Annual Sales: $-15.43
Price / Book: 1.64

Profitability

EPS (TTM): -14.42030
Net Income (TTM): $-191.1M
Gross Margin: $95.2M
Return on Equity: -10195.04%
Return on Assets: -70.54%

Sutro Biopharma, Inc. Earnings Forecast

Key Sutro Biopharma, Inc. Financial Ratios

  • The Gross Profit Margin over the past 10 years for STRO is 92.85%.
  • The Selling, General & Administrative Expenses for STRO have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 162.38% of Revenue.
  • The Net Earning history of STRO is -186.45% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

Sutro Biopharma, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: STRO
CUSIP: 869367
Website: sutrobio.com

Debt

Debt-to-Equity Ratio: -1.78
Current Ratio: 2.01
Quick Ratio: 1.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

STRO Technical Analysis vs Fundamental Analysis

Sell
37
Sutro Biopharma, Inc. (STRO) is a Sell

Is Sutro Biopharma, Inc. a Buy or a Sell?